- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x HEC: HEME C(Non-covalent)
HEC.1: 26 residues within 4Å:- Chain A: R.87, V.106, F.107, W.114, R.118, L.288, G.291, S.292, T.295, T.296, P.299, L.350, V.355, L.359, R.361, P.419, F.420, G.421, F.422, R.425, Q.426, C.427, G.429, A.433, M.437
- Ligands: O4T.2
14 PLIP interactions:14 interactions with chain A,- Hydrophobic interactions: A:F.107, A:L.288, A:P.299, A:V.355, A:L.359, A:F.420
- Hydrogen bonds: A:F.422, A:F.422
- Salt bridges: A:R.87, A:R.87, A:R.118, A:R.361, A:R.425
- Metal complexes: A:C.427
HEC.3: 25 residues within 4Å:- Chain B: R.87, V.106, F.107, W.114, R.118, L.288, G.291, S.292, T.295, T.296, P.299, L.350, V.355, L.359, R.361, P.419, F.420, G.421, F.422, R.425, C.427, L.428, G.429, A.433
- Ligands: O4T.4
17 PLIP interactions:17 interactions with chain B,- Hydrophobic interactions: B:V.106, B:F.107, B:L.288, B:P.299, B:L.350, B:V.355, B:L.359, B:F.420, B:L.428
- Hydrogen bonds: B:F.422, B:F.422
- Salt bridges: B:R.87, B:R.87, B:R.118, B:R.361, B:R.425
- Metal complexes: B:C.427
HEC.5: 27 residues within 4Å:- Chain C: R.87, V.106, F.107, W.114, R.118, L.288, G.291, S.292, T.295, T.296, P.299, L.350, V.355, L.359, R.361, P.419, F.420, G.421, F.422, R.425, Q.426, C.427, L.428, G.429, A.433, M.437
- Ligands: O4T.6
16 PLIP interactions:16 interactions with chain C,- Hydrophobic interactions: C:V.106, C:F.107, C:L.288, C:P.299, C:V.355, C:L.359, C:F.420, C:L.428
- Hydrogen bonds: C:F.422, C:F.422
- Salt bridges: C:R.87, C:R.87, C:R.118, C:R.361, C:R.425
- Metal complexes: C:C.427
- 3 x O4T: ~{N}-[(1~{R})-1-[5-(6-chloranyl-1,1-dimethyl-3-oxidanylidene-isoindol-2-yl)pyridin-3-yl]ethyl]methanesulfonamide(Non-covalent)
O4T.2: 16 residues within 4Å:- Chain A: W.93, R.97, F.107, M.207, F.208, W.237, E.287, A.290, G.291, T.295, V.355, G.356, F.358, F.464, I.465
- Ligands: HEC.1
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.93, A:F.107, A:F.208, A:A.290, A:T.295, A:V.355, A:I.465
O4T.4: 16 residues within 4Å:- Chain B: W.93, R.97, F.107, M.207, F.208, W.237, E.287, A.290, G.291, T.295, V.355, G.356, F.358, F.464, I.465
- Ligands: HEC.3
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:W.93, B:F.107, B:A.290, B:T.295, B:F.464, B:I.465
- Hydrogen bonds: B:G.356
- Halogen bonds: B:R.97
O4T.6: 16 residues within 4Å:- Chain C: W.93, R.97, F.107, M.207, F.208, W.237, E.287, A.290, G.291, T.295, V.355, G.356, F.358, F.464, I.465
- Ligands: HEC.5
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:W.93, C:F.107, C:F.208, C:A.290, C:T.295, C:I.465
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Y. et al., Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors. J.Med.Chem. (2020)
- Release Date
- 2020-06-24
- Peptides
- Cytochrome P450 11B2, mitochondrial: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.00 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x HEC: HEME C(Non-covalent)
- 3 x O4T: ~{N}-[(1~{R})-1-[5-(6-chloranyl-1,1-dimethyl-3-oxidanylidene-isoindol-2-yl)pyridin-3-yl]ethyl]methanesulfonamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Y. et al., Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) Inhibitors. J.Med.Chem. (2020)
- Release Date
- 2020-06-24
- Peptides
- Cytochrome P450 11B2, mitochondrial: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C